Sopharma Trading AD (XBUL:SFT) Debt-to-Equity : 1.81 (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Sopharma Trading AD Debt-to-Equity?

Sopharma Trading AD's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was лв193 Mil. Sopharma Trading AD's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was лв21 Mil. Sopharma Trading AD's Total Stockholders Equity for the quarter that ended in Sep. 2023 was лв118 Mil. Sopharma Trading AD's debt to equity for the quarter that ended in Sep. 2023 was 1.81.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Sopharma Trading AD's Debt-to-Equity or its related term are showing as below:

XBUL:SFT' s Debt-to-Equity Range Over the Past 10 Years
Min: 1.31 Med: 2.54 Max: 3.81
Current: 1.81

During the past 13 years, the highest Debt-to-Equity Ratio of Sopharma Trading AD was 3.81. The lowest was 1.31. And the median was 2.54.

XBUL:SFT's Debt-to-Equity is ranked worse than
89.16% of 83 companies
in the Medical Distribution industry
Industry Median: 0.29 vs XBUL:SFT: 1.81

Sopharma Trading AD Debt-to-Equity Historical Data

The historical data trend for Sopharma Trading AD's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma Trading AD Debt-to-Equity Chart

Sopharma Trading AD Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

Get a 7-Day Free Trial

3.07

3.17

3.81

3.19

2.68

Sopharma Trading AD Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial															2.41	2.68	2.24	2.29	1.81

Competitive Comparison of Sopharma Trading AD's Debt-to-Equity

For the Medical Distribution subindustry, Sopharma Trading AD's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sopharma Trading AD's Debt-to-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Sopharma Trading AD's Debt-to-Equity falls into.

Sopharma Trading AD Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Sopharma Trading AD's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(171.045	+	82.469)	/	94.545
	=	2.68

Sopharma Trading AD's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(192.514	+	21.387)	/	118.441
	=	1.81

Sopharma Trading AD (XBUL:SFT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Sopharma Trading AD Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Sopharma Trading AD's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma Trading AD (XBUL:SFT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma Trading AD (XBUL:SFT) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756

Website

http://www.sopharmatrading.bg

Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.

Sopharma Trading AD (XBUL:SFT) Headlines

No Headlines